Vehicle-engineered NK cells are superior to Motor vehicle-T cells; they appear to be safer simply because they never induce cytokine launch syndrome (CRS) they usually interact several mechanisms to market cytotoxicity188. They also lend themselves to ‘off-the shelf’ manufacturing, that is, they can be produced from peripheral blood cells or https://www.directivepublications.org/journal-of-clinical-breast-cancer/